Eprontia 25 mg/mL oral solution Images
Generic Name: topiramate
This medication has been identified as Eprontia 25 mg/mL oral solution. It is supplied by Azurity Pharmaceuticals, Inc.
Eprontia is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Eprontia 25 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Eprontia
- Generic Name
- topiramate
- Strength
- 25 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Azurity Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 52652-9001
More about Eprontia (topiramate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Topamax, Trokendi XR, Qudexy XR, Topiragen
Professional resources
Other brands
Topamax, Trokendi XR, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.